The stock of ARS Pharmaceuticals Inc (NASDAQ: SPRY) has increased by 7.66 when compared to last closing price of 13.05. Despite this, the company has
Additionally, the 36-month beta value for SPRY is 0.92. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 3
ARS Pharmaceuticals Inc (NASDAQ: SPRY)’s stock price has decreased by -4.40 compared to its previous closing price of 11.75. However, the company has seen a
ARS Pharmaceuticals Inc (NASDAQ: SPRY)’s stock price has increased by 5.76 compared to its previous closing price of 13.20. However, the company has seen a
The stock of ARS Pharmaceuticals Inc (SPRY) has gone up by 21.72% for the week, with a 47.88% rise in the past month and a
ARS Pharmaceuticals Inc (NASDAQ: SPRY) has experienced a rise in its stock price by 10.01 compared to its previous closing price of 9.89. However, the
Additionally, the 36-month beta value for SPRY is 0.82. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0
The 36-month beta value for SPRY is also noteworthy at 0.91. There are mixed opinions on the stock, with 0 analysts rating it as a
© 2024, Powered by Smart TechOne
